Kalos Medical Receives Korean MFDS Innovative Medical Device Designation for DENEX Hypertension Treatment System SEOUL, Korea, June 28, 2023 (GLOBE NEWSWIRE) -- Kalos Medical Inc. (“Kalos Medical”), a developer of innovative medical devices treating hypertension and other chronic illnesses, announced on June...

Correction -- Kalos Medical, Inc. SEOUL, South Korea, May 09, 2023 (GLOBE NEWSWIRE) -- In a release issued on Wednesday, May 3rd by Kalos Medical, Inc., please note that a revised title is being used. The corrected release follows: ...

Kalos Medical Announces Grant Award, Completion of Patient Recruitment of Clinical Trial SEOUL, South Korea, May 03, 2023 (GLOBE NEWSWIRE) -- Kalos Medical, Inc. (“Kalos”), a developer of innovative and minimally invasive medical devices using proprietary catheter-based technology,...

Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222 SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH)is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ)...